# Mounjaro.md Build Complete

## Site Overview
**Domain:** mounjaro.md  
**Topic:** Mounjaro (tirzepatide) for type 2 diabetes and weight management  
**Status:** ✅ Complete

## Files Created
- ✅ index.html — Homepage with drug overview, Q&A widget, comparison table
- ✅ dosing.html — Titration schedule (2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg)
- ✅ side-effects.html — GI side effects, pancreatitis risk, thyroid tumor warning
- ✅ cost-insurance.html — Pricing (~$900-1100/month), Lilly savings card
- ✅ faq.html — FAQ with FAQPage schema
- ✅ resources.html — Patient resources, official Mounjaro site
- ✅ blog.html — Article listing page
- ✅ llms.txt — AI crawler guidance
- ✅ robots.txt — All AI bots explicitly allowed
- ✅ sitemap.xml — All pages indexed

## Key Clinical Data
- **Average A1C reduction:** 2.0-2.5% at 15 mg dose (SURPASS trials)
- **Average weight loss:** 15-25 lbs (higher than semaglutide)
- **Dual agonist:** GLP-1 + GIP receptor agonist (novel mechanism)
- **FDA approval:** May 2022 for type 2 diabetes
- **Manufacturer:** Eli Lilly

## Comparison to Ozempic
- Mounjaro: Dual agonist (GLP-1 + GIP), higher weight loss, 6 dose levels
- Ozempic: GLP-1 only, 4 dose levels, longer market history

## Design & SEO
- ✅ Drug schema with tirzepatide as active ingredient
- ✅ FAQPage schema
- ✅ Comparison tables (Mounjaro vs Ozempic vs Trulicity)
- ✅ Teal #0d9488 color scheme
- ✅ Source Serif 4 + Inter fonts
- ✅ Medical disclaimers throughout

## Output Location
`/Users/loki/assistant/output/md-sites/weight/mounjaro/`
